ORGO: Organogenesis Holdings Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Organogenesis Holdings Inc (ORGO).
$424.24M Market Cap.
ORGO Market Cap. (MRY)
ORGO Shares Outstanding (MRY)
ORGO Assets (MRY)
Total Assets
$497.89M
Total Liabilities
$112.57M
Total Investments
$0
ORGO Income (MRY)
Revenue
$482.04M
Net Income
$861.00K
Operating Expense
$367.56M
ORGO Cash Flow (MRY)
CF Operations
$14.21M
CF Investing
-$10.03M
CF Financing
$27.64M
ORGO Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Total Assets | $497,886,000 (8.23%) | $460,025,000 (2.37%) | $449,359,000 (1.38%) | $443,259,000 (52.73%) |
Assets Current | $285,941,000 (27.06%) | $225,044,000 (1.09%) | $222,609,000 (-1.93%) | $226,979,000 (30.19%) |
Assets Non-Current | $211,945,000 (-9.80%) | $234,981,000 (3.63%) | $226,750,000 (4.84%) | $216,280,000 (86.65%) |
Goodwill & Intangible Assets | $41,240,000 (-7.62%) | $44,643,000 (-9.92%) | $49,561,000 (-8.97%) | $54,445,000 (-8.33%) |
Shareholders Equity | $262,897,000 (-5.66%) | $278,663,000 (4.89%) | $265,669,000 (10.08%) | $241,335,000 (70.18%) |
Property Plant & Equipment Net | $126,238,000 (-19.26%) | $156,346,000 (7.34%) | $145,655,000 (13.52%) | $128,304,000 (129.97%) |
Cash & Equivalents | $136,151,000 (30.49%) | $104,338,000 (1.01%) | $103,290,000 (-9.81%) | $114,528,000 (35.05%) |
Accumulated Other Comprehensive Income | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Investments | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $26,219,000 (-7.20%) | $28,253,000 (14.00%) | $24,783,000 (-0.96%) | $25,022,000 (-9.99%) |
Trade & Non-Trade Receivables | $109,861,000 (33.98%) | $81,999,000 (-8.33%) | $89,450,000 (8.48%) | $82,460,000 (45.17%) |
Trade & Non-Trade Payables | $28,911,000 (-5.90%) | $30,724,000 (-4.97%) | $32,330,000 (10.19%) | $29,339,000 (25.48%) |
Accumulated Retained Earnings (Deficit) | -$40,110,000 (2.10%) | -$40,971,000 (9.56%) | -$45,301,000 (25.53%) | -$60,833,000 (60.76%) |
Tax Assets | $39,462,000 (40.93%) | $28,002,000 (-6.70%) | $30,014,000 (-6.19%) | $31,994,000 (177644.44%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $43,312,000 (-63.71%) | $119,351,000 (-3.59%) | $123,791,000 (-6.43%) | $132,303,000 (56.07%) |
Debt Current | $9,113,000 (-53.77%) | $19,711,000 (21.33%) | $16,246,000 (10.96%) | $14,641,000 (-27.82%) |
Debt Non-Current | $34,199,000 (-65.68%) | $99,640,000 (-7.35%) | $107,545,000 (-8.60%) | $117,662,000 (82.46%) |
Total Liabilities | $112,570,000 (-37.93%) | $181,362,000 (-1.27%) | $183,690,000 (-9.03%) | $201,924,000 (36.06%) |
Liabilities Current | $77,477,000 (-3.77%) | $80,509,000 (7.31%) | $75,023,000 (-9.29%) | $82,705,000 (21.24%) |
Liabilities Non-Current | $35,093,000 (-65.20%) | $100,853,000 (-7.19%) | $108,667,000 (-8.85%) | $119,219,000 (48.67%) |
ORGO Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Revenues | $482,043,000 (11.29%) | $433,140,000 (-3.94%) | $450,893,000 (-3.52%) | $467,359,000 (38.15%) |
Cost of Revenue | $115,741,000 (8.70%) | $106,481,000 (1.39%) | $105,019,000 (-8.04%) | $114,199,000 (30.78%) |
Selling General & Administrative Expense | $294,513,000 (9.18%) | $269,754,000 (-4.95%) | $283,808,000 (13.43%) | $250,200,000 (22.53%) |
Research & Development Expense | $50,271,000 (13.27%) | $44,380,000 (11.61%) | $39,762,000 (29.34%) | $30,742,000 (53.05%) |
Operating Expenses | $367,565,000 (17.03%) | $314,077,000 (-2.94%) | $323,583,000 (15.18%) | $280,942,000 (25.26%) |
Interest Expense | $1,544,000 (-29.50%) | $2,190,000 (9.01%) | $2,009,000 (-72.24%) | $7,236,000 (-35.85%) |
Income Tax Expense | -$3,668,000 (-167.34%) | $5,447,000 (14.67%) | $4,750,000 (115.27%) | -$31,116,000 (-5970.94%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | $861,000 (-82.59%) | $4,945,000 (-68.16%) | $15,532,000 (-83.51%) | $94,202,000 (446.61%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | $861,000 (-82.59%) | $4,945,000 (-68.16%) | $15,532,000 (-83.51%) | $94,202,000 (446.61%) |
Preferred Dividends Income Statement Impact | $1,798,000 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$937,000 (-118.95%) | $4,945,000 (-68.16%) | $15,532,000 (-83.51%) | $94,202,000 (446.61%) |
Weighted Average Shares | $131,673,278 (0.34%) | $131,231,317 (0.89%) | $130,070,231 (1.36%) | $128,331,022 (19.11%) |
Weighted Average Shares Diluted | $131,673,278 (-0.81%) | $132,746,727 (0.27%) | $132,383,152 (-0.96%) | $133,662,659 (20.03%) |
Earning Before Interest & Taxes (EBIT) | -$1,263,000 (-110.04%) | $12,582,000 (-43.56%) | $22,291,000 (-68.30%) | $70,322,000 (142.13%) |
Gross Profit | $366,302,000 (12.14%) | $326,659,000 (-5.56%) | $345,874,000 (-2.06%) | $353,160,000 (40.71%) |
Operating Income | -$1,263,000 (-110.04%) | $12,582,000 (-43.56%) | $22,291,000 (-69.13%) | $72,218,000 (170.48%) |
ORGO Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Net Cash Flow from Investing | -$10,032,000 (58.82%) | -$24,364,000 (28.13%) | -$33,898,000 (-8.58%) | -$31,220,000 (-32.86%) |
Net Cash Flow from Financing | $27,637,000 (602.03%) | -$5,505,000 (-150.34%) | -$2,199,000 (-112.26%) | -$1,036,000 (-102.44%) |
Net Cash Flow from Operations | $14,208,000 (-54.04%) | $30,917,000 (24.37%) | $24,859,000 (-59.89%) | $61,978,000 (1033.88%) |
Net Cash Flow / Change in Cash & Cash Equivalents | $31,813,000 (2935.59%) | $1,048,000 (109.33%) | -$11,238,000 (-137.81%) | $29,722,000 (21.63%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Capital Expenditure | -$10,032,000 (58.82%) | -$24,364,000 (28.13%) | -$33,898,000 (-8.58%) | -$31,220,000 (-76.60%) |
Issuance (Repayment) of Debt Securities | -$67,644,000 (-1207.64%) | -$5,173,000 (-71.69%) | -$3,013,000 (-49.60%) | -$2,014,000 (87.34%) |
Issuance (Purchase) of Equity Shares | -$24,232,000 (0%) | $0 (0%) | $2,070,000 (-5.82%) | $2,198,000 (-96.45%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Share Based Compensation | $10,578,000 (17.59%) | $8,996,000 (37.30%) | $6,552,000 (69.57%) | $3,864,000 (132.63%) |
Depreciation Amortization & Accretion | $25,374,000 (8.21%) | $23,449,000 (30.05%) | $18,031,000 (8.13%) | $16,676,000 (103.79%) |
ORGO Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Gross Margin | 76.00% (0.80%) | 75.40% (-1.69%) | 76.70% (1.46%) | 75.60% (1.89%) |
Profit Margin | -0.20% (-118.18%) | 1.10% (-67.65%) | 3.40% (-83.17%) | 20.20% (296.08%) |
EBITDA Margin | 5.00% (-39.76%) | 8.30% (-6.74%) | 8.90% (-52.15%) | 18.60% (69.09%) |
Return on Average Equity (ROAE) | -0.30% (-116.67%) | 1.80% (-70.49%) | 6.10% (-87.58%) | 49.10% (102.06%) |
Return on Average Assets (ROAA) | -0.20% (-118.18%) | 1.10% (-68.57%) | 3.50% (-86.17%) | 25.30% (251.39%) |
Return on Sales (ROS) | -0.30% (-110.34%) | 2.90% (-40.82%) | 4.90% (-67.33%) | 15.00% (74.42%) |
Return on Invested Capital (ROIC) | -0.40% (-111.43%) | 3.50% (-46.97%) | 6.60% (-76.26%) | 27.80% (70.55%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | -320 (-412.96%) | 102.25 (356.13%) | 22.42 (77.10%) | 12.66 (-73.10%) |
Price to Sales Ratio (P/S) | 0.87 (-29.46%) | 1.24 (59.66%) | 0.78 (-69.41%) | 2.54 (5.80%) |
Price to Book Ratio (P/B) | 1.61 (-16.72%) | 1.94 (46.15%) | 1.33 (-73.08%) | 4.92 (-13.94%) |
Debt to Equity Ratio (D/E) | 0.43 (-34.25%) | 0.65 (-5.79%) | 0.69 (-17.44%) | 0.84 (-20.06%) |
Earnings Per Share (EPS) | -0.01 (-125.00%) | 0.04 (-66.67%) | 0.12 (-83.56%) | 0.73 (356.25%) |
Sales Per Share (SPS) | 3.66 (10.91%) | 3.3 (-4.79%) | 3.47 (-4.81%) | 3.64 (15.99%) |
Free Cash Flow Per Share (FCFPS) | 0.03 (-36.00%) | 0.05 (172.46%) | -0.07 (-128.75%) | 0.24 (312.39%) |
Book Value Per Share (BVPS) | 2 (-5.93%) | 2.12 (3.92%) | 2.04 (8.61%) | 1.88 (42.93%) |
Tangible Assets Book Value Per Share (TABVPS) | 3.47 (9.57%) | 3.17 (2.96%) | 3.07 (1.45%) | 3.03 (41.46%) |
Enterprise Value Over EBIT (EV/EBIT) | -345 (-866.67%) | 45 (164.71%) | 17 (0.00%) | 17 (-45.16%) |
Enterprise Value Over EBITDA (EV/EBITDA) | 18.07 (15.44%) | 15.65 (69.73%) | 9.22 (-33.03%) | 13.77 (-42.37%) |
Asset Turnover | 1.04 (9.77%) | 0.95 (-4.99%) | 1 (-20.22%) | 1.26 (-10.73%) |
Current Ratio | 3.69 (32.06%) | 2.79 (-5.80%) | 2.97 (8.13%) | 2.74 (7.36%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | $4,176,000 (-36.27%) | $6,553,000 (172.50%) | -$9,039,000 (-129.39%) | $30,758,000 (351.87%) |
Enterprise Value (EV) | $435,701,806 (-22.75%) | $564,037,361 (51.67%) | $371,880,616 (-68.96%) | $1,198,010,643 (34.69%) |
Earnings Before Tax (EBT) | -$2,807,000 (-127.01%) | $10,392,000 (-48.76%) | $20,282,000 (-67.85%) | $63,086,000 (255.13%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | $24,111,000 (-33.08%) | $36,031,000 (-10.64%) | $40,322,000 (-53.65%) | $86,998,000 (133.70%) |
Invested Capital | $286,330,000 (-18.16%) | $349,886,000 (1.34%) | $345,276,000 (6.60%) | $323,884,000 (99.22%) |
Working Capital | $208,464,000 (44.23%) | $144,535,000 (-2.07%) | $147,586,000 (2.30%) | $144,274,000 (35.94%) |
Tangible Asset Value | $456,646,000 (9.93%) | $415,382,000 (3.90%) | $399,798,000 (2.83%) | $388,814,000 (68.45%) |
Market Capitalization | $424,244,806 (-21.44%) | $540,048,361 (53.35%) | $352,161,616 (-70.37%) | $1,188,648,643 (46.45%) |
Average Equity | $270,743,750 (-0.69%) | $272,627,750 (6.95%) | $254,902,500 (32.98%) | $191,680,750 (170.61%) |
Average Assets | $461,456,500 (1.47%) | $454,773,000 (1.10%) | $449,815,000 (20.88%) | $372,106,750 (54.81%) |
Invested Capital Average | $329,645,250 (-7.58%) | $356,680,000 (6.35%) | $335,369,000 (32.66%) | $252,811,250 (42.22%) |
Shares | 132,576,502 (0.41%) | 132,041,164 (0.86%) | 130,915,099 (1.77%) | 128,641,628 (19.35%) |